What does Dr. Nickmans - Dr. Morren do?

Dr. Nickmans - Dr. Morren is a general practice in Kortenaken. Private Limited, started on 9 January 1992.

What is the address of Dr. Nickmans - Dr. Morren?

The registered office of Dr. Nickmans - Dr. Morren is located at Dorpsstraat 52, 3470 Kortenaken.

Is Dr. Nickmans - Dr. Morren still active?

Yes. According to the CBE (16 September 2026) Dr. Nickmans - Dr. Morren is active, legal situation “Normale toestand”, started on 9 January 1992.

Is Dr. Nickmans - Dr. Morren registered on Peppol?

Yes, Dr. Nickmans - Dr. Morren is registered on the Peppol network with ID 0208:0446330355.

What is the enterprise number of Dr. Nickmans - Dr. Morren?

The enterprise number of Dr. Nickmans - Dr. Morren is BE0446330355.

When was Dr. Nickmans - Dr. Morren founded?

Dr. Nickmans - Dr. Morren was founded on 9 January 1992.

Who are the directors of Dr. Nickmans - Dr. Morren?

According to the 2025 annual accounts, the directors of Dr. Nickmans - Dr. Morren are: Rudolf NICKMANS, Nelly MORREN.

Is Dr. Nickmans - Dr. Morren a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 January 1992; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Dr. Nickmans - Dr. Morren make in 2025?

Dr. Nickmans - Dr. Morren posted a profit after taxes of € 271,823 in financial year 2025.

What is the revenue of Dr. Nickmans - Dr. Morren?

As a small company, Dr. Nickmans - Dr. Morren is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 424,516.

Dr. Nickmans - Dr. Morren (Private Limited) - Kortenaken

Dossier Dr. Nickmans - Dr. Morren, printed on 16 September 2026 from databakkes.be/en/0446330355/dr-nickmans-dr-morren. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Nickmans - Dr. Morren from Kortenaken, company number BE0446330355, closed financial year 2025 with a result of € 271,823 after tax. For that financial year Dr. Nickmans - Dr. Morren recorded a gross margin of € 424,516 and equity of € 1.9 million. Compared with financial year 2024, the result moved from € 298,257 to € 271,823. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.

What it is worth Growing

€ 1.9 million

▲ 17% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 271,823

▼ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 162,621

▲ 2% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.8 million.

People and assets in 2025

Vehicles and equipment

€ 40,162

▼ 20% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 6,378

▼ 35% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 215,425 Gross margin 2022: € 215,425 First fiscal year in the series	€ 287,498 Gross margin 2023: € 287,498 ▲ 33% vs 2022 (€ 215,425) Favourable step	€ 432,323 Gross margin 2024: € 432,323 ▲ 50% vs 2023 (€ 287,498) Favourable step	€ 424,516 Gross margin 2025: € 424,516 ▼ 2% vs 2024 (€ 432,323) Unfavourable step	▼ 2%
Profit after taxes	€ 70,044 Profit after taxes 2022: € 70,044 First fiscal year in the series	€ 163,357 Profit after taxes 2023: € 163,357 ▲ 133% vs 2022 (€ 70,044) Favourable step	€ 298,257 Profit after taxes 2024: € 298,257 ▲ 83% vs 2023 (€ 163,357) Favourable step	€ 271,823 Profit after taxes 2025: € 271,823 ▼ 9% vs 2024 (€ 298,257) Unfavourable step	▼ 9%
Equity	€ 1,130,054 Equity 2022: € 1,130,054 First fiscal year in the series	€ 1,293,410 Equity 2023: € 1,293,410 ▲ 14% vs 2022 (€ 1,130,054) Favourable step	€ 1,591,667 Equity 2024: € 1,591,667 ▲ 23% vs 2023 (€ 1,293,410) Favourable step	€ 1,863,490 Equity 2025: € 1,863,490 ▲ 17% vs 2024 (€ 1,591,667) Favourable step	▲ 17%
Total debts	€ 316,100 Total debts 2022: € 316,100 First fiscal year in the series	€ 326,676 Total debts 2023: € 326,676 ▲ 3% vs 2022 (€ 316,100) Unfavourable step	€ 208,201 Total debts 2024: € 208,201 ▼ 36% vs 2023 (€ 326,676) Favourable step	€ 94,076 Total debts 2025: € 94,076 ▼ 55% vs 2024 (€ 208,201) Favourable step	▼ 55%
Cash	€ 391,606 Cash 2022: € 391,606 First fiscal year in the series	€ 520,045 Cash 2023: € 520,045 ▲ 33% vs 2022 (€ 391,606) Favourable step	€ 159,532 Cash 2024: € 159,532 ▼ 69% vs 2023 (€ 520,045) Unfavourable step	€ 162,621 Cash 2025: € 162,621 ▲ 2% vs 2024 (€ 159,532) Favourable step	▲ 2%
Land & buildings	€ 755,870 Land & buildings 2022: € 755,870 First fiscal year in the series	€ 730,888 Land & buildings 2023: € 730,888 ▼ 3% vs 2022 (€ 755,870) Unchanged	€ 705,906 Land & buildings 2024: € 705,906 ▼ 3% vs 2023 (€ 730,888) Unchanged	€ 680,923 Land & buildings 2025: € 680,923 ▼ 4% vs 2024 (€ 705,906) Unchanged	▼ 4%
Retained profit	€ 1,111,454 Retained profit 2022: € 1,111,454 First fiscal year in the series	€ 1,274,810 Retained profit 2023: € 1,274,810 ▲ 15% vs 2022 (€ 1,111,454) Favourable step	€ 1,573,067 Retained profit 2024: € 1,573,067 ▲ 23% vs 2023 (€ 1,274,810) Favourable step	€ 1,844,890 Retained profit 2025: € 1,844,890 ▲ 17% vs 2024 (€ 1,573,067) Favourable step	▲ 17%
Balance sheet total	€ 1,446,154 Balance sheet total 2022: € 1,446,154 First fiscal year in the series	€ 1,620,086 Balance sheet total 2023: € 1,620,086 ▲ 12% vs 2022 (€ 1,446,154) Unchanged	€ 1,799,869 Balance sheet total 2024: € 1,799,869 ▲ 11% vs 2023 (€ 1,620,086) Unchanged	€ 1,957,567 Balance sheet total 2025: € 1,957,567 ▲ 9% vs 2024 (€ 1,799,869) Unchanged	▲ 9%

Key figures of Dr. Nickmans - Dr. Morren, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Nickmans - Dr. Morren?

What happened at Dr. Nickmans - Dr. Morren in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 10, 2026 New annual accounts for financial year 2025: profit of € 271,823 (▼ 9% vs 2024). Source: NBB ↗
Jan 9, 1992 Start of the company according to the CBE. KBO

In short

From € 70,044 profit in 2022 to € 271,823 profit in 2025.

Paid € 376,040 in corporate taxes since 2022.

Best year ever: 2024, with € 298,257 profit.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Nickmans - Dr. Morren? We notify you, reason included.

Follow Dr. Nickmans - Dr. Morren

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Rudolf NICKMANS Nelly MORREN

Dr. Nickmans - Dr. Morren

Behind Dr. Nickmans - Dr. Morren are Rudolf NICKMANS and Nelly MORREN.

See the full network in the app

Directors

According to the 2025 annual accounts

Rudolf NICKMANS

Director

Nelly MORREN

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Dorpsstraat 52

3470 Kortenaken

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Bredor

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0446.330.355

VAT number

BE 0446.330.355

Registered office

Dorpsstraat 52, 3470 Kortenaken

Names & denominations

Dr. Nickmans - Dr. Morren

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

9 January 1992

Peppol

Active · Active since 4 Dec 2025

Activities · NACE

Activiteiten van huisartspraktijken

Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Nickmans - Dr. Morren

Financials

What happened to Dr. Nickmans - Dr. Morren?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions